US High Intensity Focused Ultrasound
Treats primary and recurrent prostate cancer using HIFU (high intensity focused ultrasound), a minimally invasive outpatient procedure which potentially improves patients quality of life. US HIFU manufactures the Sonablate 500, manages and funds two FDA clinical trials and is working to increase access to the technology in locations outside the U.S. where it is has been approved.
2011 STATISTICS
3-year growth:45%
2010 Revenue:$13.6 million
2007 Revenue:$9.4 million
Employees:63
Jobs added, prev. 3 years:41
PREVIOUS INC. 5000 RANKINGS
2009
597
